Does LOMUSTINE Cause Second primary malignancy? 31 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 31 reports of Second primary malignancy have been filed in association with LOMUSTINE (LOMUSTINE). This represents 1.9% of all adverse event reports for LOMUSTINE.
31
Reports of Second primary malignancy with LOMUSTINE
1.9%
of all LOMUSTINE reports
18
Deaths
7
Hospitalizations
How Dangerous Is Second primary malignancy From LOMUSTINE?
Of the 31 reports, 18 (58.1%) resulted in death, 7 (22.6%) required hospitalization, and 3 (9.7%) were considered life-threatening.
Is Second primary malignancy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LOMUSTINE. However, 31 reports have been filed with the FAERS database.
What Other Side Effects Does LOMUSTINE Cause?
Death (169)
Off label use (135)
Thrombocytopenia (127)
Disease progression (106)
Neutropenia (92)
Drug ineffective (88)
Fatigue (71)
Nausea (68)
Platelet count decreased (63)
Malignant neoplasm progression (62)
What Other Drugs Cause Second primary malignancy?
CYCLOPHOSPHAMIDE (1,247)
DOXORUBICIN (1,151)
VINCRISTINE (908)
IMATINIB (763)
PALBOCICLIB (658)
RITUXIMAB (646)
RUXOLITINIB (611)
ETOPOSIDE (573)
PREDNISONE (517)
OCTREOTIDE (496)
Which LOMUSTINE Alternatives Have Lower Second primary malignancy Risk?
LOMUSTINE vs LONAPEGSOMATROPIN-TCGD
LOMUSTINE vs LONCASTUXIMAB TESIRINE-LPYL
LOMUSTINE vs LOPERAMIDE
LOMUSTINE vs LOPINAVIR
LOMUSTINE vs LOPINAVIR\RITONAVIR